Skip to content

Hearing · house

"Lives Worth Living: Addressing the Fentanyl Crisis, Protecting Critical Lifelines, and Combatting Discrimination Against Those with Disabilities"

2023-02-01 · 15:00

Source status: Scheduled

Committee

Location

2123, Rayburn House Office Building

Video

Considered

Witnesses

  1. Mr. Kemp Chester

    Senior Advisor, Office of National Drug Control Policy

  2. Dr. Stephen Loyd

    Chief Medical Officer, Cedar Recovery

  3. Dr. Timothy Westlake

    Emergency Medicine Physician

  4. Mr. Frederick Isasi

    Executive Director, Families USA

  5. Ms. Kandi Pickard

    President and CEO, National Down Syndrome Society

  6. Ms. Molly Cain

    Parent Advocate

  7. Dr. Neeraj Gandotra

    Chief Medical Officer, Substance Abuse and Mental Health Services Administration

  8. Mr. Jon DeLena

    Associate Administrator, Business Operations, Drug Enforcement Administration

Official published hearing

Congress.gov explicitly associates this publication with this proceeding.

  • H.Hrg.118

    LIVES WORTH LIVING: ADDRESSING THE FENTANYL CRISIS, PROTECTING CRITICAL LIFELINES, AND COMBATING DISCRIMINATION AGAINST THOSE WITH DISABILITIES

    2023-02-01 · GovInfo record 2023-08-24

Congress.gov lists this publication among several possible proceedings.

Documents

Committee activity

Source: https://api.congress.gov/v3/committee-meeting/118/house/115361